His successor was Emil Buergi from Bern who hold the title of the director of the institute of pharmacology for 36 years. His salary per year was 5000 sFr. (at least before the stock market crash in 1929) and the staff increased by an assistant and a secretary. His scientific focus was first on secretion and toxicity of mercury, arsen and combinations of brom. Later he analyzed the potency of anesthetics, combination of medicines and dose-response behavior. During the second world war Prof. E. Buergi retired 70 years old (1942). He died in 1947 leaving behind the "Buergi foundation" from which we profit even today.
A new topic was brought in when Walther Wildbrandt became chief of the institute in 1946. His interests were transport processes across the cell membrane. Under this general principle he investigated the regulation of heart contractions by calcium ions. His most important contributions where studies about sugar translocation across biological membrane. In addition Prof. W. Wildbrandt succeeded in realising the idea of a new building for the institute of pharmacology which you can see at the top of the page. The flourishing economy in the 60ies allowed to increase the staff up to 14 persons reaching a maximum of 35 persons in the lavishing 80ies. Impressed by his predecessor Prof. W. Wildbrandt stayed for 32 years at the top of the institute. He retired in 1977 and died two years later.
Already in 1972 Harald Reuter became managing director at the institute. In 1978 Marcel H. Bickel was appointed to the vacant professorship and a codirectorium of Prof. H. Reuter and Prof. M.H. Bickel was established based on a rotational principle. Prof. Bickel retired in 1993 and Prof. Reuter in 1999.
In 2000, Prof. Hans-Uwe Simon was appointed as new chair and director. He built up a new research focus of immunopharmacology that obtained high international reputation over the next twenty years. In 2021, he was appointed president of the Medical School in Brandenburg (Germany) and therefore reduced his work load in Bern, but still kept his research ongoing. In 2021, Prof. Andrea Huwiler was appointed as a managing director ad interim of the Institute. With Prof. Huwiler, the first female Full professor of Pharmacology and head of the Institute came into charge.
Source: Simon HU, Reuter H, Bickel MH: Pharmakologisches Institut, Medizinische Fakultät Bern. In: Geschichte der pharmakologischen, klinisch-pharmakologischen und toxikologischen Institute im deutschsprachigen Raum (Ed. A. Philippou), Berenkamp Verlag, Innsbruck, 2004, p. 94-101.